Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001815776-25-000071
Filing Date
2025-11-05
Accepted
2025-11-05 16:10:20
Documents
60
Period of Report
2025-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q lenz-20250930.htm   iXBRL 10-Q 1531419
2 EX-31.1 exhibit311q325.htm EX-31.1 10577
3 EX-31.2 exhibit312q325.htm EX-31.2 10580
4 EX-32.1 exhibit321q325.htm EX-32.1 5278
5 EX-32.2 exhibit322q325.htm EX-32.2 5281
  Complete submission text file 0001815776-25-000071.txt   6678353

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lenz-20250930.xsd EX-101.SCH 41518
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT lenz-20250930_cal.xml EX-101.CAL 57810
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lenz-20250930_def.xml EX-101.DEF 209245
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lenz-20250930_lab.xml EX-101.LAB 566153
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lenz-20250930_pre.xml EX-101.PRE 379927
63 EXTRACTED XBRL INSTANCE DOCUMENT lenz-20250930_htm.xml XML 799935
Mailing Address 201 LOMAS SANTA FE DRIVE, SUITE 300 SOLANA BEACH CA 92075
Business Address 201 LOMAS SANTA FE DRIVE, SUITE 300 SOLANA BEACH CA 92075 858-925-7000
LENZ Therapeutics, Inc. (Filer) CIK: 0001815776 (see all company filings)

EIN.: 844867570 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40532 | Film No.: 251454045
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)